Medications

Breast cancer medication risk

New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.

Medications

Research helps pave way for newly approved use of drug

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) ...